FORTYSSIMO Trademark

Trademark Overview


On Thursday, January 18, 2024, a trademark application was filed for FORTYSSIMO with the United States Patent and Trademark Office. The USPTO has given the FORTYSSIMO trademark a serial number of 79389844. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, December 12, 2024. This trademark is owned by Genmab A/S. The FORTYSSIMO trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system and for the treatment of cancer, autoimmune diseases, and inflammatory disorders

Medical and pharmacological research services; medical and scientific research services, namely conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
fortyssimo

General Information


Serial Number79389844
Word MarkFORTYSSIMO
Filing DateThursday, January 18, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, December 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 31, 2024

Trademark Statements


Goods and ServicesPharmaceuticals for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system and for the treatment of cancer, autoimmune diseases, and inflammatory disorders
Goods and ServicesMedical and pharmacological research services; medical and scientific research services, namely conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, February 24, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, February 24, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGenmab A/S
Party Type10 - Original Applicant
Legal Entity Type65 - NOT AVAILABLE
AddressDK

Trademark Events


Event DateEvent Description
Thursday, February 22, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Saturday, February 24, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 28, 2024APPLICATION FILING RECEIPT MAILED
Tuesday, August 13, 2024ASSIGNED TO EXAMINER
Thursday, August 29, 2024ASSIGNED TO EXAMINER
Saturday, August 31, 2024NON-FINAL ACTION WRITTEN
Sunday, September 1, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 3, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, September 3, 2024REFUSAL PROCESSED BY MPU
Saturday, September 21, 2024REFUSAL PROCESSED BY IB
Friday, December 6, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 6, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 6, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 9, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 25, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED